Roche Denies Diabetes Sale Rumors

Feb 03, 2017


Roche has dismissed recent reports that said the drugmaker was considering exiting the diabetes business.

Instead, Roche is looking to expand its $2 billion-per-year diabetes biz -- not sell it or spin it off, said Diagnostics division head Roland Diggelmann.

Rumors started after Bloomberg reported that Roche was open to a possible spin-off or a partial stake sale of its diabetes care unit, claiming that private equity players and medical device makers had expressed interest in acquiring the business.

Despite Roche's 5% decline in revenues for the unit, Roche says that it remains committed to diabetes care.

Read the Reuters coverage

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments